Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Wearable Biomedical Device Helps Combat Diabetes

By LabMedica International staff writers
Posted on 05 Apr 2016
An innovative graphene-based patch is capable of noninvasive blood sugar monitoring and feedback therapy by analyzing human sweat. More...


Developed by researchers at the Institute for Basic Science (IBS; Daejeon, Republic of Korea) the patch integrates electrochemically-active and soft functional materials on a gold-doped graphene and serpentine-shape gold mesh hybrid patch. The enzyme-based glucose sensor also enables systematic corrections of sweat glucose measurements as affected by pH and temperature, while a humidity sensor monitors the increase in relative humidity (RH). About 15 minutes are needed for the sweat-uptake layer of the patch to reach a RH over 80%, at which time glucose and pH measurements are initiated.

If abnormally high levels of glucose are detected, drugs can be released into the bloodstream via loaded microneedles. In an experiment to test the patch on diabetic mice, microneedles pierced the skin of the mouse near the abdomen, releasing Metformin into the bloodstream. The mice treated with microneedles showed a significant suppression of blood glucose concentrations with respect to control groups. The malleable, semi-transparent, skin-like appearance of the GP device also provides comfortable contact with human skin. The study was published on March 22, 2016, in Nature Nanotechnology.

“Our wearable GP-based device is capable of not only sweat-based glucose and pH monitoring, but also controlled transcutaneous drug delivery through temperature-responsive microneedles,” said lead author Kim Dae-Hyeong, PhD, of the IBS Center for Nanoparticle Research. “One can easily replace the used microneedles with new ones. Treatment with Metformin through the skin is more efficient than that through the digestive system because the drug is directly introduced into metabolic circulation.”

Type II diabetes affects some three million Koreans, with the figure increasing due to dietary patterns and an aging society. The current treatments available to diabetics are painful, inconvenient and costly, and regular visits to a doctor and home testing kits are needed to record glucose levels. Patients also have to inject uncomfortable insulin shots to regulate glucose levels. According to IBS, the device could facilitate the process and reduce lengthy and expensive cycles of visiting doctors and pharmacies.

Related Links:

Institute for Basic Science



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.